DNA methylation and hydroxymethylation characterize the identity of D1 and D2 striatal projection neurons.
Lucile Marion-PollJean-Pierre RoussarieLieng TaingCloelia Dard-DascotNicolas ServantYan JaszczyszynEmmanuelle JordiEskeatnaf MulugetaDenis HervéDéborah Bourc'hisPaul GreengardClaude ThermesJean-Antoine GiraultPublished in: Communications biology (2022)
Neuronal DNA modifications differ from those in other cells, including methylation outside CpG context and abundant 5-hydroxymethylation whose relevance for neuronal identities are unclear. Striatal projection neurons expressing D1 or D2 dopamine receptors allow addressing this question, as they share many characteristics but differ in their gene expression profiles, connections, and functional roles. We compare translating mRNAs and DNA modifications in these two populations. DNA methylation differences occur predominantly in large genomic clusters including differentially expressed genes, potentially important for D1 and D2 neurons. Decreased gene body methylation is associated with higher gene expression. Hydroxymethylation differences are more scattered and affect transcription factor binding sites, which can influence gene expression. We also find a strong genome-wide hydroxymethylation asymmetry between the two DNA strands, particularly pronounced at expressed genes and retrotransposons. These results identify novel properties of neuronal DNA modifications and unveil epigenetic characteristics of striatal projection neurons heterogeneity.
Keyphrases
- dna methylation
- genome wide
- gene expression
- copy number
- circulating tumor
- cell free
- single molecule
- spinal cord
- transcription factor
- parkinson disease
- functional connectivity
- image quality
- cerebral ischemia
- circulating tumor cells
- nucleic acid
- cell death
- magnetic resonance
- uric acid
- metabolic syndrome
- cell cycle arrest
- genome wide analysis
- brain injury
- signaling pathway
- african american